HomeCompareCLPIF vs PFE

CLPIF vs PFE: Dividend Comparison 2026

CLPIF yields 4.80% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLPIF wins by $4896.92M in total portfolio value
10 years
CLPIF
CLPIF
● Live price
4.80%
Share price
$26.61
Annual div
$1.28
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4896.97M
Annual income
$4,708,575,728.78
Full CLPIF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CLPIF vs PFE

📍 CLPIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLPIFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLPIF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLPIF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLPIF
Annual income on $10K today (after 15% tax)
$408.11/yr
After 10yr DRIP, annual income (after tax)
$4,002,289,369.46/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, CLPIF beats the other by $4,002,267,049.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLPIF + PFE for your $10,000?

CLPIF: 50%PFE: 50%
100% PFE50/50100% CLPIF
Portfolio after 10yr
$2448.51M
Annual income
$2,354,300,993.75/yr
Blended yield
96.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CLPIF
No analyst data
Altman Z
1.4
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLPIF buys
0
PFE buys
0
No recent congressional trades found for CLPIF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLPIFPFE
Forward yield4.80%6.13%
Annual dividend / share$1.28$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$4896.97M$49.6K
Annual income after 10y$4,708,575,728.78$26,258.71
Total dividends collected$4883.71M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLPIF vs PFE ($10,000, DRIP)

YearCLPIF PortfolioCLPIF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,660$960.27$9,153$693.39+$2.5KCLPIF
2$14,569$2,092.89$8,593$849.25+$6.0KCLPIF
3$20,477$4,887.94$8,336$1,066.78+$12.1KCLPIF
4$34,752$12,841.06$8,437$1,384.80+$26.3KCLPIF
5$77,918$40,733.57$9,013$1,875.40+$68.9KCLPIF
6$254,083$170,710.47$10,306$2,680.72+$243.8KCLPIF
7$1,312,374$1,040,505.54$12,820$4,101.38+$1.30MCLPIF
8$11,449,782$10,045,541.79$17,673$6,826.70+$11.43MCLPIF
9$176,068,363$163,817,096.79$27,543$12,591.86+$176.04MCLPIF
10$4,896,968,878$4,708,575,728.78$49,560$26,258.71+$4896.92MCLPIF

CLPIF vs PFE: Complete Analysis 2026

CLPIFStock

Compagnie des Alpes SA, together with its subsidiaries, operates leisure facilities. It operates through Ski Areas, Leisure Parks, and Holdings and Supports segments. The Ski Areas segment operates ski lifts; and equips, maintains, and operates ski areas, as well as maintains ski runs and trails. It also sells land to real-estate developers. This segment operates ski resorts under the La Plagne, Les Arcs, Peisey-Vallandry, Tignes, Val d'Isère, Les Menuires, Méribel, Flaine, Serre Chevalier, Les Deux Alpes, Samoëns, and Megeve. The Leisure Parks segment develops and operates theme parks, combined amusement and animal parks, water parks, wax museums, and tourist sites. This segment operates leisure parks under Parc Astérix, Futuroscope, Grévin Paris, France Miniature, Walibi Rhône-Alpes, Walibi Holland, Walibi Belgium, Aqualibi, Bellewaerde, Aquapark, and Familypark. The Holdings and Supports segment is involved in the provision of consulting services; and tour-operator, travel agency, and real estate businesses. Compagnie des Alpes SA was founded in 1989 and is headquartered in Paris, France.

Full CLPIF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CLPIF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLPIF vs SCHDCLPIF vs JEPICLPIF vs OCLPIF vs KOCLPIF vs MAINCLPIF vs JNJCLPIF vs MRKCLPIF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.